<?xml version="1.0" encoding="utf-8" standalone="no"?>
<measures>
  <measure>
    <type>Main</type>
    <parent-measure></parent-measure>
    <title>Percentage of written meeting responses that were sent greater than two FDA business days in advance of the meeting (1)</title>
    <dictionary>This measure focuses on the timeliness of providing written responses to pre-meeting questions that are submitted by sponsors before a scheduled face-to-face meeting.  OBRR's goal is to provide comprehensive responses prior to the meeting to further advance the exchange of information leading to more efficient product development.</dictionary>
    <dictionary>&lt;i&gt;Information is current as of September 30, 2012&lt;/i&gt;</dictionary>
    <footnotes>
      <note>(1) FDA business days are Monday through Friday.</note>
    </footnotes>
    <measure-description>Percent</measure-description>
    <chart-type></chart-type>
    <chart-color></chart-color>
    <right-min></right-min>
    <right-max></right-max>
    <fiscal-year>
      <chart-min>0</chart-min>
      <chart-max>100</chart-max>
      <title>2011</title>
      <target-header></target-header>
      <target-description></target-description>
      <summary>FY 2011 Overall: 73%</summary>
      <time>
        <frame>Oct 2010</frame>
        <target>75</target>
        <value>93</value>
      </time>
      <time>
        <frame>Nov 2010</frame>
        <target>75</target>
        <value>100</value>
      </time>
      <time>
        <frame>Dec 2010</frame>
        <target>75</target>
        <value>80</value>
      </time>
      <time>
        <frame>Jan 2011</frame>
        <target>75</target>
        <value>100</value>
      </time>
      <time>
        <frame>Feb 2011</frame>
        <target>75</target>
        <value>60</value>
      </time>
      <time>
        <frame>Mar 2011</frame>
        <target>75</target>
        <value>60</value>
      </time>
      <time>
        <frame>Apr 2011</frame>
        <target>75</target>
        <value>60</value>
      </time>
      <time>
        <frame>May 2011</frame>
        <target>75</target>
        <value>47</value>
      </time>
      <time>
        <frame>Jun 2011</frame>
        <target>75</target>
        <value>67</value>
      </time>
      <time>
        <frame>Jul 2011</frame>
        <target>75</target>
        <value>71</value>
      </time>
      <time>
        <frame>Aug 2011</frame>
        <target>75</target>
        <value>78</value>
      </time>
      <time>
        <frame>Sep 2011</frame>
        <target>75</target>
        <value>75</value>
      </time>
    </fiscal-year>
    <fiscal-year>
      <chart-min>0</chart-min>
      <chart-max>100</chart-max>
      <title>2012</title>
      <target-header></target-header>
      <target-description></target-description>
      <summary>FY 2012 Overall: 70%</summary>
      <time>
        <frame>Oct 2011</frame>
        <target>75</target>
        <value>85</value>
      </time>
      <time>
        <frame>Nov 2011</frame>
        <target>75</target>
        <value>72</value>
      </time>
      <time>
        <frame>Dec 2011</frame>
        <target>75</target>
        <value>100</value>
      </time>
      <time>
        <frame>Jan 2012</frame>
        <target>75</target>
        <value>60</value>
      </time>
      <time>
        <frame>Feb 2012</frame>
        <target>75</target>
        <value>80</value>
      </time>
      <time>
        <frame>Mar 2012</frame>
        <target>75</target>
        <value>78</value>
      </time>
      <time>
        <frame>Apr 2012</frame>
        <target>75</target>
        <value>83</value>
      </time>
      <time>
        <frame>May 2012</frame>
        <target>75</target>
        <value>55</value>
      </time>
      <time>
        <frame>Jun 2012</frame>
        <target>75</target>
        <value>75</value>
      </time>
      <time>
        <frame>Jul 2012</frame>
        <target>75</target>
        <value>57</value>
      </time>
      <time>
        <frame>Aug 2012</frame>
        <target>75</target>
        <value>25</value>
      </time>
      <time>
        <frame>Sep 2012</frame>
        <target>75</target>
        <value>86</value>
      </time>
    </fiscal-year>
  </measure>
  <measure>
    <type>Sub</type>
    <parent-measure>Percentage of written meeting responses that were sent greater than two FDA business days in advance of the meeting (1)</parent-measure>
    <title>Number of written meeting responses during the month that were faxed/emailed greater than two FDA business days in advance of the meeting</title>
    <dictionary></dictionary>
    <footnotes>
      <note></note>
    </footnotes>
    <measure-description>Number</measure-description>
    <chart-type>column</chart-type>
    <chart-color></chart-color>
    <right-min></right-min>
    <right-max></right-max>
    <fiscal-year>
      <chart-min></chart-min>
      <chart-max></chart-max>
      <title>2011</title>
      <target-header></target-header>
      <target-description></target-description>
      <summary>FY 2011 Total: 77</summary>
      <time>
        <frame>Oct 2010</frame>
        <target></target>
        <value>13</value>
      </time>
      <time>
        <frame>Nov 2010</frame>
        <target></target>
        <value>11</value>
      </time>
      <time>
        <frame>Dec 2010</frame>
        <target></target>
        <value>4</value>
      </time>
      <time>
        <frame>Jan 2011</frame>
        <target></target>
        <value>3</value>
      </time>
      <time>
        <frame>Feb 2011</frame>
        <target></target>
        <value>3</value>
      </time>
      <time>
        <frame>Mar 2011</frame>
        <target></target>
        <value>3</value>
      </time>
      <time>
        <frame>Apr 2011</frame>
        <target></target>
        <value>6</value>
      </time>
      <time>
        <frame>May 2011</frame>
        <target></target>
        <value>9</value>
      </time>
      <time>
        <frame>Jun 2011</frame>
        <target></target>
        <value>4</value>
      </time>
      <time>
        <frame>Jul 2011</frame>
        <target></target>
        <value>5</value>
      </time>
      <time>
        <frame>Aug 2011</frame>
        <target></target>
        <value>7</value>
      </time>
      <time>
        <frame>Sep 2011</frame>
        <target></target>
        <value>9</value>
      </time>
    </fiscal-year>
    <fiscal-year>
      <chart-min></chart-min>
      <chart-max></chart-max>
      <title>2012</title>
      <target-header></target-header>
      <target-description></target-description>
      <summary>FY 2012 Total: 72</summary>
      <time>
        <frame>Oct 2011</frame>
        <target></target>
        <value>11</value>
      </time>
      <time>
        <frame>Nov 2011</frame>
        <target></target>
        <value>13</value>
      </time>
      <time>
        <frame>Dec 2011</frame>
        <target></target>
        <value>5</value>
      </time>
      <time>
        <frame>Jan 2012</frame>
        <target></target>
        <value>6</value>
      </time>
      <time>
        <frame>Feb 2012</frame>
        <target></target>
        <value>4</value>
      </time>
      <time>
        <frame>Mar 2012</frame>
        <target></target>
        <value>7</value>
      </time>
      <time>
        <frame>Apr 2012</frame>
        <target></target>
        <value>5</value>
      </time>
      <time>
        <frame>May 2012</frame>
        <target></target>
        <value>6</value>
      </time>
      <time>
        <frame>Jun 2012</frame>
        <target></target>
        <value>3</value>
      </time>
      <time>
        <frame>Jul 2012</frame>
        <target></target>
        <value>4</value>
      </time>
      <time>
        <frame>Aug 2012</frame>
        <target></target>
        <value>2</value>
      </time>
      <time>
        <frame>Sep 2012</frame>
        <target></target>
        <value>6</value>
      </time>
    </fiscal-year>
  </measure>
  <measure>
    <type>Sub</type>
    <parent-measure>Percentage of written meeting responses that were sent greater than two FDA business days in advance of the meeting (1)</parent-measure>
    <title>Number of written meeting responses during the month that were faxed/emailed two FDA business days or less in advance of the meeting</title>
    <dictionary></dictionary>
    <footnotes>
      <note></note>
    </footnotes>
    <measure-description>Number</measure-description>
    <chart-type>column</chart-type>
    <chart-color></chart-color>
    <right-min></right-min>
    <right-max></right-max>
    <fiscal-year>
      <chart-min>0</chart-min>
      <chart-max>15</chart-max>
      <title>2011</title>
      <target-header></target-header>
      <target-description></target-description>
      <summary>FY 2011 Total: 29</summary>
      <time>
        <frame>Oct 2010</frame>
        <target></target>
        <value>1</value>
      </time>
      <time>
        <frame>Nov 2010</frame>
        <target></target>
        <value>0</value>
      </time>
      <time>
        <frame>Dec 2010</frame>
        <target></target>
        <value>1</value>
      </time>
      <time>
        <frame>Jan 2011</frame>
        <target></target>
        <value>0</value>
      </time>
      <time>
        <frame>Feb 2011</frame>
        <target></target>
        <value>2</value>
      </time>
      <time>
        <frame>Mar 2011</frame>
        <target></target>
        <value>2</value>
      </time>
      <time>
        <frame>Apr 2011</frame>
        <target></target>
        <value>4</value>
      </time>
      <time>
        <frame>May 2011</frame>
        <target></target>
        <value>10</value>
      </time>
      <time>
        <frame>Jun 2011</frame>
        <target></target>
        <value>2</value>
      </time>
      <time>
        <frame>Jul 2011</frame>
        <target></target>
        <value>2</value>
      </time>
      <time>
        <frame>Aug 2011</frame>
        <target></target>
        <value>2</value>
      </time>
      <time>
        <frame>Sep 2011</frame>
        <target></target>
        <value>3</value>
      </time>
    </fiscal-year>
    <fiscal-year>
      <chart-min>0</chart-min>
      <chart-max>15</chart-max>
      <title>2012</title>
      <target-header></target-header>
      <target-description></target-description>
      <summary>FY 2012 Total: 31</summary>
      <time>
        <frame>Oct 2011</frame>
        <target></target>
        <value>2</value>
      </time>
      <time>
        <frame>Nov 2011</frame>
        <target></target>
        <value>5</value>
      </time>
      <time>
        <frame>Dec 2011</frame>
        <target></target>
        <value>0</value>
      </time>
      <time>
        <frame>Jan 2012</frame>
        <target></target>
        <value>4</value>
      </time>
      <time>
        <frame>Feb 2012</frame>
        <target></target>
        <value>1</value>
      </time>
      <time>
        <frame>Mar 2012</frame>
        <target></target>
        <value>2</value>
      </time>
      <time>
        <frame>Apr 2012</frame>
        <target></target>
        <value>1</value>
      </time>
      <time>
        <frame>May 2012</frame>
        <target></target>
        <value>5</value>
      </time>
      <time>
        <frame>Jun 2012</frame>
        <target></target>
        <value>1</value>
      </time>
      <time>
        <frame>Jul 2012</frame>
        <target></target>
        <value>3</value>
      </time>
      <time>
        <frame>Aug 2012</frame>
        <target></target>
        <value>6</value>
      </time>
      <time>
        <frame>Sep 2012</frame>
        <target></target>
        <value>1</value>
      </time>
    </fiscal-year>
  </measure>
  <related-links>
    <link>
      <url>http://www.fda.gov/AboutFDA/Transparency/track/ucm206804.htm</url>
      <text>FDA-TRACK CBER Dashboard</text>
    </link>
  </related-links>
  <glossary>
    <word>
      <text>word text</text>
      <definition>word defintion</definition>
    </word>
  </glossary>
</measures>਍††਍਍਍਍਍਍਍